Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Associate professor

Total project amount

139,21 thousand €

Amount paid

0 €

Non-refundable funding

139,21 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.13694.TENURE.039

Summary

The prospective employee is expected to work as an Associate Professor in the field of Bioengineering. The employee is expected to work in research and teaching activities at the Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS) of the Faculty of Medicine of the University of Porto. In particular, the employee is expected to work on data sciences computing, cell biology and drug delivery in silico for personalized medicine and therapeutic innovation. The employee is expected to have knowledge and experience in doing research and teaching in these fields. In addition, the employee is expected to have a biomedical background and knowledge and experience in data sciences, therapeutics and innovation.MEDCIDS has a relevant research and teaching track record in the Bioengineering field. The Bioengineering division at MEDCIDS is inherently interdisciplinary, amalgamating research endeavours spanning biomedical and clinical data. Within bioengineering, we fuse disciplines such as biomedicine and bioinformatics with physical and life sciences, leveraging mathematical and computational sciences in tandem with pharmacology. This convergence empowers us to grasp the intricacies of biological systems´ functionality and devise innovative solutions to pivotal challenges in medicine and biology. This is indicated by the number of studies published by its members and by the participation in technology transfer and services provision activities (involving public, private, national or international entities – e.g., participation in health technology assessment reports of the Portuguese drug agency or in economic evaluation studies hired by pharmaceutical companies) or for having the CHAIR in Onco-Innovation. This research activity is done in close connection with the Associate Laboratory RISE (Health Research Network). In fact, Thematic Line 4 of RISE is fully dedicated to health policy and digital transformation, having as its scope “development and assessment of methods and technologies to improve biomedical sciences and healthcare”. Also, this research activity is done closely with Line 2 of RISE, dedicated to Clinical and Translational Research Oncology.MEDCIDS has also displayed a vibrant teaching activity in the health technology field, with contents on economic evaluation studies, decision-making, and guidelines. Understanding both molecular and functional paradigms within individuals is the key to enhancing treatment efficacy and providing more personalized medicine. Many of the projects in these areas are part of the Doctoral Program in Clinical and Health Services Research and of the Master’s Degree in Evidence and Decision in Health. In addition, these contents are taught in the Health Data Sciences Doctoral Programme (all these programmes are hosted at MEDCIDS). Topics on Bioengineering will also be of key importance to the BSc course in Digital Health in Biomedical Innovation, particularly its branch of Biomedical Research and Bioinformatics, or Clinical Research and Innovation Management in Health. Of note, several of the partners of this BSc course correspond to public or private entities with whom MEDCIDS has collaborated in technology transfer or service provision activities. Given this background and the need to further develop research and teaching activities in this field, hiring an Associate Professor in the Bioengineering area is necessary.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

8,5
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

139,21 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Porto 139,21 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading